Angola vs Guyana: Cause of death, by non-communicable diseases, ages 15-59, male
Angola
38.7%
in 2021
Guyana
38.2%
in 2021
Angola rank
141st
Guyana rank
143rd
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Angola
- Guyana
How they compare
Angola currently reports 38.7% against 38.2% in Guyana, a difference of 0.5%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Guyana ahead.
Angola ranks 141st and Guyana ranks 143rd of 185 countries.
Guyana has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Angola | Guyana | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 32.8% | 48.0% | 15.2% | Guyana |
| 2010s | 36.6% | 48.5% | 11.9% | Guyana |
| 2020s | 39.3% | 43.4% | 4.1% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Angola or Guyana?
- Angola, at 38.7% against 38.2% in Guyana as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Angola and Guyana?
- 0.5%, with Angola ahead.
- How many years of comparable data are there for Angola and Guyana?
- 6 years are reported by both, from 2000 to 2021.
- How do Angola and Guyana rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Angola ranks 141st and Guyana ranks 143rd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.